CNS toxicity and high-dose busulphan in three patients undergoing bone marrow transplantation
Vasta, S.; Scimé, R.; Indovina, A.; Majolino, I.
Haematologica 77(2): 189
1992
ISSN/ISBN: 0390-6078 PMID: 1398309 Document Number: 390953
Document emailed within 1 workday
Related Documents
Angelucci, E.; Polchi, P.; Lucarelli, G.; Galimberti, M.; Baronciani, D.; Giardini, C.; Durazzi, S.M.; Moretti, L.; Donati, M. 1989: Allogeneic bone marrow transplantation for hematological malignancies following therapy with high doses of busulphan and cyclophosphamide Haematologica 74(5): 455-461Michon, J.; Négrier, S.; Coze, C.; Mathiot, C.; Frappaz, D.; Oskam, R.; Pacquement, H.; Quintana, E.; Bouffet, E.; Bernard, J.L. 1994: Administration of high-dose recombinant interleukin 2 after autologous bone marrow transplantation in patients with neuroblastoma: toxicity, efficacy and survival. a Lyon-Marseille-Curie-east of France Group Study Progress in Clinical and Biological Research 385: 293-300
Kessinger, A.; Vose, J.M.; Bierman, P.J.; Armitage, J.O. 1991: High-dose therapy and autologous peripheral stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: an alternative to bone marrow purging Experimental Hematology 19(10): 1013-1016
Verdonck, L.F.; Vendrik, C.P.; Dekker, A.W.; van Kempen, M.L.; Schornagel, J.H.; Rozenberg-Arska, M.; de Gast, G.C. 1985: High dose cytotoxic agents followed by autologous bone marrow transplantation; treatment results in 25 patients with various malignancies Nederlands Tijdschrift Voor Geneeskunde 129(25): 1186-1190
Rühl, U. 2000: Consolidation radiotherapy after high-dose chemotherapy and autologous bone marrow transplantation in patients with advanced breast cancer Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 176(4): 196-197
Ahmed, T.; Ciavarella, D.; Feldman, E.; Ascensao, J.; Hussain, F.; Engelking, C.; Gingrich, S.; Mittelman, A.; Coleman, M.; Arlin, Z.A. 1989: High-dose, potentially myeloablative chemotherapy and autologous bone marrow transplantation for patients with advanced Hodgkin's disease Leukemia 3(1): 19-22
De Kreuk, M.; Ossenkoppele, G.J.; Meijer, C.J.; Huijgens, P.C. 1996: Prognostic factors for survival of non-Hodgkin's lymphoma patients treated with high-dose chemotherapy and autologous bone marrow transplantation Bone Marrow Transplantation 17(6): 963-971
Chen, T.L.; Passos-Coelho, J.L.; Noe, D.A.; Kennedy, M.J.; Black, K.C.; Colvin, O.M.; Grochow, L.B. 1995: Nonlinear pharmacokinetics of cyclophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation Cancer Research 55(4): 810-816
Vellodi, A.; Jurges, E.; el-Tumi, M.; Abdul-Ahad, A.; Hobbs, J.R. 1991: Bone marrow transplantation from unrelated donors for genetic diseases following conditioning with Busulphan and Cyclophosphamide Bone Marrow Transplantation 7(Suppl 2): 70
Mesía, R.; Solá, C.; López Pousa, A.; Mendoza, L.; Bellet, M.; Andrés, L.; López López, J.J. 1994: High-dose chemotherapy and autologous bone marrow transplantation in high-grade metastatic sarcomas Revista Clinica Espanola 194(11): 960-965
Krance, R.A.; Forman, S.J.; Blume, K.G. 1987: Total-body irradiation and high-dose teniposide: a pilot study in bone marrow transplantation for patients with relapsed acute lymphoblastic leukemia Cancer Treatment Reports 71(6): 645-647
Schouten, H.C.; Maragos, D.; Vose, J.; Armitage, J.O. 1990: Diabetes mellitus or an impaired glucose tolerance as a potential complicating factor in patients treated with high-dose therapy and autologous bone marrow transplantation Bone Marrow Transplantation 6(5): 333-335
Wu, D.P.; Milpied, N.; Moreau, P.; Mechinaud-Lacroix, F.; Mahe, B.; Le Tortorec, S.; Rapp, M.J.; Bourdin, S.; Mahe, J.M.; Harousseau, J.L. 1994: Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies Bone Marrow Transplantation 14(5): 751-757
Fasola, G.; Lo Greco, P.; Calori, E.; Zilli, M.; Verlicchi, F.; Motta, M.R.; Ricci, P.; Baccarani, M.; Tura, S. 1991: Pharmacokinetics of high-dose cyclophosphamide for bone marrow transplantation Haematologica 76(2): 120-125
Gorin, N.C.; Najman, A.; David, R.; Stachowiak, J.; Hirsch Marie, F.; Muller, J.Y.; Petit, J.C.; Leblanc, G.; Parlier, Y.; Jullien, A.M.; Cavalier, J.; Salmon, C.; Duhamel, G. 1978: High dose combination chemotherapy with and without autologous bone marrow transplantation in patients with solid tumors and acute leukemias. Kinetics of recovery of peripheral bloods cells La Nouvelle Presse Medicale 7(45): 4105-4110
Fine, H.A.; Antman, K.H. 1992: High-dose chemotherapy with autologous bone marrow transplantation in the treatment of high grade astrocytomas in adults: therapeutic rationale and clinical experience Bone Marrow Transplantation 10(4): 315-321
Takeyama, K.; Tobinai, K.; Shimoyama, M. 1992: High dose chemotherapy with autologous bone marrow transplantation and G-CSF for hematologic malignancies Nihon Rinsho. Japanese Journal of Clinical Medicine 50(6): 1414-1418
Montalbano, M.; Gatta, N. 1986: Nursing care for patients undergoing bone marrow transplantation Professioni Infermieristiche 39(3): 227-245
Bacigalupo, A.; Avanzi, G.; Van Lint, M.T.; Reali, G.; Solda', A.; Adami, R.; Strada, P.; Barbanti, M.; Podesta', M.; Marmont, A. 1981: Platelet support in patients undergoing bone marrow transplantation Haematologica 66(1): 80-90
Wolff, S.N.; Herzig, R.H.; Fay, J.W.; LeMaistre, C.F.; Brown, R.A.; Frei-Lahr, D.; Stranjord, S.; Giannone, L.; Coccia, P.; Weick, J.L. 1990: High-dose N,N',N"-triethylenethiophosphoramide (thiotepa) with autologous bone marrow transplantation: phase i studies Seminars in Oncology 17(1 Suppl 3: 2-6